Patent · US Active

Substituted nucleosides, nucleotides and analogs thereof

US10112966B2 · kind B2 · utility

13Cited by
43References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 2, 2016
Grant dateOct 30, 2018
Priority date—
Expiry dateSep 2, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H19/213
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a HCV infection with one or more nucleotide analogs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.